U-Blot® Research Grade damlecovateinCat. No. WA2656$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade damlecovateinCat. No. WA2656
U-Blot® Research Grade Dalutrafusp AlfaCat. No. WA2655
U-Blot® Research Grade DalotuzumabCat. No. WA2654
U-Blot® Research Grade DalnicastobartCat. No. WA2653
U-Blot® Research Grade DalmitamigCat. No. WA2652
U-Blot® Research Grade dalidnetugCat. No. WA2651
U-Blot® Research Grade DalanterceptCat. No. WA2650
U-Blot® Research Grade DafsolimabCat. No. WA2649
U-Blot® Research Grade DaclizumabCat. No. WA2648
U-Blot® Research Grade DacetuzumabCat. No. WA2647
U-Blot® Research Grade CusatuzumabCat. No. WA2646
U-Blot® Research Grade CugrastomigCat. No. WA2645